PC
ARNA

Polar Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Polar Capital’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$435K Hold
5,816
– – ﹤0.01% 281
2020
Q2 		$366K Sell
5,816
-4,622
-44% -$254K ﹤0.01% 260
2020
Q1 		$438K Buy
+10,438
New +$479K ﹤0.01% 273
2017
Q4 		– Sell
-150,000
Closed -$3.83M – 278
2017
Q3 		$3.83M Buy
+150,000
New +$3.44M 0.04% 208

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Polar Capital's ARNA Position: Q3 2020 in Review

Polar Capital held its Arena Pharmaceuticals Inc (ARNA) position steady in Q3 2020 at 5,816 shares worth $435K. The position accounts for ﹤0.01% of the portfolio, ranked #281.

Polar Capital first reported a position in ARNA in Q3 2017 and has held it in 4 quarters since. The position peaked at $3.83M in Q3 2017. 253 funds tracked by Wall St. Rank hold ARNA as of Q3 2020.

  • Polar Capital held 5,816 shares of Arena Pharmaceuticals Inc worth $435K as of Q3 2020.
  • Polar Capital left its Arena Pharmaceuticals Inc share count unchanged in Q3 2020.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of Polar Capital's portfolio in Q3 2020, its #281 holding.
  • Polar Capital first reported a position in Arena Pharmaceuticals Inc in Q3 2017 and has held it in 4 quarters since.
  • Polar Capital's Arena Pharmaceuticals Inc position peaked at $3.83M in Q3 2017.
  • 253 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.